Form4insider filings, from the source

Insider holders · CIK 0001802768

Royalty Pharma plc · RPRX

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Pablo G. LegorretaCEO, Chairman of the Board1,307,8206,9301,314,750Aug 7, 2026 · 5:24 pm EDTForm 4
Christopher HiteEVP & Chairman, Partnering23,200270,401293,601Sep 24, 2026 · 4:10 pm EDTForm 4
Gregory NordenDirector196,348—196,348Jun 8, 2026 · 4:28 pm EDTForm 4
Bonnie L BasslerDirector79,181—79,181Jun 30, 2026 · 5:15 pm EDTForm 4
Ted W LoveDirector58,393—58,393Jun 8, 2026 · 4:27 pm EDTForm 4
Catherine M. EngelbertDirector55,673—55,673Jun 8, 2026 · 4:22 pm EDTForm 4
David C HodgsonDirector37,873—37,873Jun 8, 2026 · 4:26 pm EDTForm 4
Marshall UristEVP, Research & Investments8,25219,02027,272Aug 7, 2026 · 5:11 pm EDTForm 4
Vlad CoricDirector15,343—15,343Jun 8, 2026 · 4:21 pm EDTForm 4
Carole HoDirector4,5458,55813,103Jun 8, 2026 · 4:24 pm EDTForm 4
Elizabeth H WeathermanDirector13,103—13,103Jun 8, 2026 · 4:29 pm EDTForm 4
Terrance P. CoyneEVP & CFO1,5001,4502,950Aug 17, 2026 · 5:01 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.